Sequence information
DRAVP ID DRAVPc006
Name Fibrin-derived peptide
Sequence
Molecular Formula C133H216N44O38
Condition/Disease COVID-19
Group Phase Ⅱ clinical trial
Type Peptide
Description FX-06 is a fibrin-derived synthetic peptide used for treatment of vascular leak syndrome in Ebola virus disease, Phase 2 trials for COVID-19 treatment.
Active sequence/Structure
External Links
DrugBank Accession Number Not Available
Pubchem ID 16208062
CHEMBL ID Not Available
UNII Not Available
CAS 88650-17-3
ClinicalTrails Information
| NCT Number | Study Title | Condition/Disease | Status | Phase | Sponsor |
|---|---|---|---|---|---|
| NCT04618042 | FX06 to Rescue Acute Respiratory Distress Syndrome During Covid-19 Pneumonia (FX-COVID) | COVID-19 | Completed | Phase 2 | Assistance Publique - Hôpitaux de Paris |
